SEC Form 4 · accession 0001513162-18-000124
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Catelani
Officer — Chief Operating Officer
Period of report
May 8, 2018
Accepted (ET)
May 14, 2018 · 7:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock OptionF1 | $3.70 | May 8, 2018 | A | 500,000 | A | — | May 8, 2028 | Common Stock | 500,000 | 500,000 | D |
Explanation of responses
- F1The option vests and becomes exercisable in equal installments on a monthly basis over three years beginning on May 31, 2018.